Plasma-derived versus recombinant Factor VIII concentrates for the treatment of haemophilia A: recombinant is better.
Franchini
Massimo
M
Immunohematology and Transfusion Center, Department of Laboratory and Pathology Medicine, University Hospital of Parma, Parma, Italy. mfranchini@ao.pr.it
D005169:Factor VIII / Q000276:immunology / Q000627:therapeutic use*; D006467:Hemophilia A / Q000276:immunology / Q000628:therapy*; D006801:Humans; D011994:Recombinant Proteins / Q000276:immunology / Q000627:therapeutic use*
D011994:Recombinant Proteins; D005169:Factor VIII